Enable early detection of congenital CMV infection

By DiaSorin Molecular

For over 40 years, DiaSorin Molecular has been developing, producing and commercialising diagnostic tests in a wide range of clinical areas including paediatrics, oncology, women’s health and infectious diseases. The company is about to launch its first Simplexa kit for the detection of congenital human cytomegalovirus (CMV), which poses significant dangers to newborns all across the globe.

Enter your details below to view the free white paper

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.